GeoMx Digital Spatial Profiler
GPTKB entity
Statements (57)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Research_Institute
|
gptkbp:appliesTo |
cancer research
neuroscience research immunology research |
gptkbp:developedBy |
gptkb:NanoString_Technologies
|
gptkbp:enables |
analysis of tissue samples
tissue architecture |
gptkbp:features |
spatial resolution
high-throughput capabilities |
gptkbp:hasCollaboratedWith |
academic institutions
pharmaceutical companies |
gptkbp:hasRelatedPatent |
personalized medicine
|
https://www.w3.org/2000/01/rdf-schema#label |
GeoMx Digital Spatial Profiler
|
gptkbp:integratesWith |
bioinformatics tools
|
gptkbp:isAttendedBy |
software for data analysis
|
gptkbp:isAvailableIn |
various configurations
|
gptkbp:isCompatibleWith |
fresh frozen samples
FFPE_samples |
gptkbp:isEnhancedBy |
machine learning algorithms
|
gptkbp:isMarketedAs |
advanced spatial profiling solution
|
gptkbp:isPartOf |
multi-omics approaches
spatial omics NanoString's_product_portfolio |
gptkbp:isPromotedBy |
scientific conferences
|
gptkbp:isPromotedThrough |
workshops
training sessions webinars |
gptkbp:isRecognizedBy |
clinical laboratories
research institutions |
gptkbp:isSupportedBy |
scientific publications
technical support services |
gptkbp:isTrainedIn |
large datasets
|
gptkbp:isUsedBy |
immune response
cell signaling pathways disease mechanisms tumor evolution tissue interactions |
gptkbp:isUsedIn |
drug development
biomarker_discovery therapeutic_research |
gptkbp:isUtilizedFor |
researchers
biotech companies clinicians pathologists pharmaceutical researchers |
gptkbp:isUtilizedIn |
clinical trials
|
gptkbp:mayHave |
RNA
proteins cellular markers |
gptkbp:provides |
tumor microenvironment
cellular heterogeneity quantitative gene expression data |
gptkbp:providesAccessTo |
spatial context of gene expression
|
gptkbp:supports |
clinical research
preclinical studies |
gptkbp:usedFor |
high-plex spatial profiling
|
gptkbp:utilizes |
multiplexed imaging technology
|